menu
    • menu

    Company profile for Achilles Therapeutics

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Achilles Therapeutics is a biopharmaceutical company developing novel cancer immunotherapies targeting clonal neoantigens: protein markers unique to each individual that are expressed on the surface of every cancer cell. Achilles uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell...
    Achilles Therapeutics is a biopharmaceutical company developing novel cancer immunotherapies targeting clonal neoantigens: protein markers unique to each individual that are expressed on the surface of every cancer cell. Achilles uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. Targeting multiple clonal neoantigens that are present on all cancer cells, but not on healthy cells, allows individualised treatments to target and destroy tumours without harming healthy tissues.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Achilles Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2FX, UK
    Telephone
    Telephone
    +44 (0)1438 906 855
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://achillestx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Achilles Therapeutics Plans Nasdaq Delisting & SEC Deregistration
    Achilles Therapeutics Plans Nasdaq Delisting & SEC Deregistration

    28 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/28/3034633/0/en/Achilles-Therapeutics-Announces-Voluntary-Nasdaq-Delisting-and-SEC-Deregistration.html

    GLOBENEWSWIRE
    28 Feb 2025
    Share Share
    Achilles Announces Sale of Technology Assets to AstraZeneca
    Achilles Announces Sale of Technology Assets to AstraZeneca

    26 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/24/3001719/0/en/Achilles-Therapeutics-Announces-Sale-of-Technology-Assets-to-AstraZeneca.html

    GLOBENEWSWIRE
    26 Dec 2024
    Share Share
    Achilles Therapeutics Approved to Transfer to Nasdaq Capital Market
    Achilles Therapeutics Approved to Transfer to Nasdaq Capital Market

    19 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/19/2983431/0/en/Achilles-Therapeutics-Receives-Approval-to-Transfer-to-Nasdaq-Capital-Market.html

    GLOBENEWSWIRE
    19 Nov 2024
    Share Share
    Achilles Therapeutics Reports Third Quarter 2024 Financial Results
    Achilles Therapeutics Reports Third Quarter 2024 Financial Results

    14 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/14/2980995/0/en/Achilles-Therapeutics-Reports-Third-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    14 Nov 2024
    Share Share
    Achilles Therapeutics Announces Strategic Update
    Achilles Therapeutics Announces Strategic Update

    19 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/19/2948865/0/en/Achilles-Therapeutics-Announces-Strategic-Update.html

    GLOBENEWSWIRE
    19 Sep 2024
    Share Share
    Achilles Drops Cell Therapy, Plans Layoffs
    Achilles Drops Cell Therapy, Plans Layoffs

    19 Sep 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/achilles-drops-cell-therapy-program-prepares-lay-staff-after-missing-commercial-viability

    FIERCE BIOTECH
    19 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search